MARIMED INC - stock earnings

MRMD Quarterly earnings

DateEarningsRevenue
2023Q4 -10.2 million USD 38.9 million USD
2023Q3 -4.3 million USD 38.8 million USD
2023Q2 -958000 USD 36.5 million USD
2023Q1 -645000 USD 34.4 million USD
2022Q4 4.8 million USD 35.8 million USD
2022Q3 2.7 million USD 33.9 million USD
2022Q2 1.8 million USD 33.0 million USD
2022Q1 4.2 million USD 31.3 million USD
2021Q4 -6.5 million USD 31.0 million USD
2021Q3 2.0 million USD 33.2 million USD
2021Q2 7.5 million USD 32.6 million USD
2021Q1 4.2 million USD 24.6 million USD
2020Q4 4.1 million USD 20.4 million USD
2020Q3 1.7 million USD 13.5 million USD
2020Q2 -1.2 million USD 9.6 million USD
2020Q1 -2.4 million USD 7.5 million USD
2019Q4 -78.4 million USD 5.2 million USD
2019Q3 -7.4 million USD 11.2 million USD
2019Q2 4.7 million USD 25.7 million USD
2019Q1 -23211 USD 3.5 million USD
2018Q4 4.8 million USD 3.4 million USD
2018Q3 -10.2 million USD 3.4 million USD
2018Q2 -6.3 million USD 2.9 million USD
2018Q1 -1.9 million USD 2.1 million USD
2017Q4 -1.0 million USD 1.3 million USD
2017Q3 -521043 USD 2.3 million USD
2017Q2 547000 USD 1.6 million USD
2017Q1 -32240 USD 1.2 million USD
2016Q4 11337 USD 1.4 million USD

MRMD Yearly earnings

DateEarningsRevenue
2023 -16.0 million USD 148.6 million USD
2022 13.5 million USD 134.0 million USD
2021 7.2 million USD 121.5 million USD
2020 2.1 million USD 50.9 million USD
2019 -81.2 million USD 45.6 million USD
2018 -13.6 million USD 11.9 million USD
2017 -1.2 million USD 6.1 million USD
2016 -198852 USD 3.6 million USD
2015 -1.2 million USD 1.3 million USD
2014 -7.2 million USD 88384 USD

MRMD

Price: $0.30

52 week price:
0.20
0.55

Earnings Per Share: -0.04 USD

P/E Ratio: -37.80

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 278400

Market Capitalization: 89.1 million

Links: